Oncology Highlights - July 2018
Mistimed meals and increased risk of cancer, how reward mechanism boosts immunity, rapid gene editing, European VC climb, IO/IO combination approvals
Oncology Highlights - June 2018
Novel ACT therapy, Vitamin D and lowered cancer risk, iTeos secures $75M, EMA guidance on Brexit
Oncology Highlights - May 2018
Achilles heel in drug-resistant cancer, smart Nanobombs, Lilly's IO spree, Xenikos secure Series B funding..
Oncology Highlights - April 2018
Organoid cultures, NGS in clinical trials, latest Onco M&A and more..
Oncology Highlights - March 2018
ctDNA as liquid biopsy, PET scan for PD-L1 and recent analysis in the European cancer death rate..
ASCO 2018 recap - pembro the way to go?
The 2018 Annual Meeting of the American Society of Clinical Oncology (ASCO) gathered over 32.000 oncology professionals from all over the world, highlighting the latest in cancer care treatments.
AACR2018 - Emerging trends in next generation immunotherapy
Chicago hosted the 2018 annual meeting of the American Association for Cancer Research (AACR) in its cold spring days. As expected, enthusiasm centered on immunotherapy combination therapy and its challenges, and the possibilit...
The future of data management in clinical trials - ACDM 2018
On March 13, Brussels was considered the capital of Data Management, hosting the annual conference of the Association for Clinical Data Management (ACDM). Since technologies and standards continue to evolve in the ever changing...
Power of targeted, personalized and combined therapies - TAT 2018
The home of Phase I oncology conference a.k.a. the Targeted Anticancer Therapies (TAT) conference took place this week in the beautiful city of Paris. The program is dedicated to early-phase development and translational resear...
EMA anticancer drug recommendations for approval in 2017
In 2017, the European Medicines Agency (EMA) made a total of 92 positive recommendations to the European Commission for medicines to receive marketing approval. Approximately one fourth (23/92) were aimed at cancer treatment, w...